ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2012

Aug 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2012-07-30

Reporting Person: Cormack Scott Daniel (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-30	Common Stock	M	34167	$4.1051	Acquired	47234	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-30	Stock Option	$4.1051	M	34167	Disposed	2012-08-08	Common (34167)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8092	Indirect
Common Stock	49340	Indirect

Footnotes

F1: The reporting person and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1